Modeling of Corticosteroid Pharmacogenomics in Rat Liver Using Gene Microarrays

Corticosteroid (CS) pharmacogenomics was studied using gene microarrays in rat liver. Methylprednisolone (MPL) was administered intravenously at 50 mg/kg. Rats were sacrificed and liver excised at 17 time points over 72 h. RNAs from individual livers were used to query Affymetrix GeneChips that contain sequences for 8000 genes. Cluster analysis revealed six temporal patterns consisting of 197 CS-responsive probes representing 143 genes. Based on our fifth-generation model of CS pharmacokinetics/pharmacodynamics (PK/PD), mechanistic models were developed to describe the time pattern for each CS-responsive gene. Two clusters showed increased expression with different effect duration. PK/PD models assuming CS stimulation of mRNA synthesis were applied. Another two clusters showed an initial decline followed by delayed increase, suggesting two mechanisms might be involved jointly. The initial suppression was captured by CS inhibition of mRNA synthesis or stimulation of degradation. CS may also stimulate the production of a biosignal (transcription factors or other hormones), which can cause secondary induction of the target mRNA. One cluster showed a very abrupt increase in message followed by rapid decrease. These genes were lymphocytic in origin and were modeled combining the fast gene induction effect of CS in lymphoid cells and its direct lymphocyte trafficking effect. Another cluster showed reduction persisting for 18 h, which was described by CS inhibition of mRNA synthesis. Our results reveal the marked diversity of genes regulated by CS via a limited array of mechanisms. These PK/PD models provide quantitation of CS pharmacogenomics and new hypotheses regarding understanding of diverse mechanisms of CS receptor-gene mediated action.

[1]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[2]  P. Feigelson,et al.  Glucocorticoid induction of alpha2u-globulin protein synthesis and its mRNA in rat hepatocytes in vitro. , 1978, The Journal of biological chemistry.

[3]  Glucocorticoid induction of hepatic alpha2u-globulin synthesis and messenger RNA level in castrated male rats in vivo. , 1978, The Journal of biological chemistry.

[4]  RNA polymerase and ribonuclease activities in skeletal muscle of prednisolone-treated rats. , 1981, Enzyme.

[5]  M. Leider Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .

[6]  R. Vaillant,et al.  Effects of corticosteroids and pancreatic hormones on carbamyl phosphate synthetase-I and ornithine transcarbamylase activities in fetal rat liver. , 1985, Biology of the neonate.

[7]  C. Banner,et al.  Dexamethasone regulates glutamine synthetase expression in rat skeletal muscles. , 1988, The American journal of physiology.

[8]  O. Jänne,et al.  Effect of dexamethasone on the activity and expression of ornithine decarboxylase in rat liver and thymus. , 1988, Biochimica et biophysica acta.

[9]  C. Berdanier Role of glucocorticoids in the regulation of lipogenesis , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  H. R. Allen,et al.  Regulation of glucocorticoid receptor protein and mRNA levels. , 1989, Cancer research.

[11]  F. Wiebel,et al.  Dexamethasone-mediated potentiation of P450IA1 induction in H4IIEC3/T hepatoma cells is dependent on a time-consuming process and associated with induction of the Ah receptor. , 1990, Chemico-biological interactions.

[12]  J. Hargrove,et al.  Microcomputer‐assisted kinetic modeling of mammalian gene expression , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Oakley Rh,et al.  Homologous down regulation of the glucocorticoid receptor: the molecular machinery. , 1993 .

[14]  J. Cidlowski,et al.  Homologous down regulation of the glucocorticoid receptor: the molecular machinery. , 1993, Critical reviews in eukaryotic gene expression.

[15]  W. Jusko Receptor-mediated pharmacodynamics of corticosteroids. , 1994, Progress in clinical and biological research.

[16]  M. Takiguchi,et al.  The delayed glucocorticoid-responsive and hepatoma cell-selective enhancer of the rat arginase gene is located around intron 7. , 1994, Journal of biochemistry.

[17]  A. D. Rodrigues,et al.  Regulation of the Ah gene battery via Ah receptor-dependent and independent processes in cultured adult rat hepatocytes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[18]  M. Takiguchi,et al.  Transcriptional regulation of genes for ornithine cycle enzymes. , 1995, The Biochemical journal.

[19]  M. Takiguchi,et al.  Induction of the C/EBP beta gene by dexamethasone and glucagon in primary-cultured rat hepatocytes. , 1996, Journal of biochemistry.

[20]  R. Prough,et al.  Hormonal regulation of hepatic enzymes involved in foreign compound metabolism , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  M. Takiguchi,et al.  The Glucocorticoid-responsive Gene Cascade , 1997, The Journal of Biological Chemistry.

[22]  R. Maynard,et al.  The Pharmacological Basis of Therapeutics. 9th ed , 1997 .

[23]  P. Herrlich,et al.  Transcriptional cross-talk, the second mode of steroid hormone receptor action , 1998, Journal of Molecular Medicine.

[24]  W J Jusko,et al.  Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. , 1998, Journal of pharmaceutical sciences.

[25]  E. Morand,et al.  Glucocorticoid regulation of inflammation: The plot thickens , 1999, Inflammation Research.

[26]  D. DuBois,et al.  Pharmacokinetic/Pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a Receptor/Gene-mediated mechanism. , 1999, The Journal of pharmacology and experimental therapeutics.

[27]  D. Dettmer,et al.  Effects of Dexamethasone and Glucagon after Long-Term Exposure on Cyclic AMP Phosphodiesterase 4 in Cultured Rat Hepatocytes , 1999 .

[28]  C. Watson,et al.  Membrane-Initiated Steroid Actions and the Proteins that Mediate Them , 1999 .

[29]  J. Check,et al.  Salpingectomy for Unilateral Hydrosalpinx May Improve in vivo Fecundity , 1999, Gynecologic and Obstetric Investigation.

[30]  B. Walker,et al.  Glucocorticoids and insulin resistance: old hormones, new targets. , 1999, Clinical science.

[31]  E. Falkenstein,et al.  Multiple actions of steroid hormones--a focus on rapid, nongenomic effects. , 2000, Pharmacological reviews.

[32]  T. Slaga,et al.  Altered skin development and impaired proliferative and inflammatory responses in transgenic mice overexpressing the glucocorticoid receptor , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  Debra C DuBois,et al.  Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats. , 2002, The Journal of pharmacology and experimental therapeutics.

[34]  Shuzhong Zhang,et al.  Pharmacodynamics and Pharmacogenomics of Diverse Receptor-Mediated Effects of Methylprednisolone in Rats Using Microarray Analysis , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[35]  Richard R. Almon,et al.  Fourth-Generation Model for Corticosteroid Pharmacodynamics: A Model for Methylprednisolone Effects on Receptor/Gene-Mediated Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.

[36]  Richard R. Almon,et al.  Gene arrays and temporal patterns of drug response: corticosteroid effects on rat liver , 2003, Functional & Integrative Genomics.

[37]  W. Jusko,et al.  Modeling Interactions between Adrenal Suppression and T-Helper Lymphocyte Trafficking during Multiple Dosing of Methylprednisolone , 1999, Journal of Pharmacokinetics and Biopharmaceutics.

[38]  R. Ramakrishnan,et al.  Fifth-Generation Model for Corticosteroid Pharmacodynamics: Application to Steady-State Receptor Down-Regulation and Enzyme Induction Patterns During Seven-Day Continuous Infusion of Methylprednisolone in Rats , 2002, Journal of Pharmacokinetics and Pharmacodynamics.

[39]  N. Pyszczynski,et al.  Pharmacokinetic and Pharmacoimmunodynamic Interactions Between Prednisolone and Sirolimus in Adrenalectomized Rats , 1999, Journal of Pharmacokinetics and Biopharmaceutics.